| P50 | author | Edward D Frohlich | Q106568148 |
| P2093 | author name string | Dinko Susic | |
| P2860 | cites work | Weight loss and the renin-angiotensin-aldosterone system | Q45209925 |
| | Body mass index and risk for end-stage renal disease | Q46876497 |
| | Obesity paradox in patients with hypertension and coronary artery disease | Q46975339 |
| | Cardiovascular Changes After Weight Reduction in Obesity Hypertension | Q47257178 |
| | Intima-media thickness in obese children before and after weight loss | Q47311546 |
| | Combined renal effects of overweight and hypertension. | Q51585541 |
| | Renal injury in obese Zucker rats: glomerular hemodynamic alterations and effects of enalapril | Q51604476 |
| | Renal haemodynamic studies in obesity hypertension. | Q54402038 |
| | Hemodynamic factors in the pathogenesis and maintenance of hypertension. | Q54516547 |
| | Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity. | Q54542487 |
| | Disparate Effects of Left Ventricular Geometry and Obesity on Mortality in Patients With Preserved Left Ventricular Ejection Fraction | Q57652833 |
| | Disparate cardiovascular effects of obesity and arterial hypertension | Q70249027 |
| | Hypertension in obese patients: hemodynamic and volume studies | Q70287302 |
| | Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output | Q70367740 |
| | Dimorphic cardiac adaptation to obesity and arterial hypertension | Q71124726 |
| | Insulin resistance, elevated glomerular filtration fraction, and renal injury | Q71173616 |
| | Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function | Q71721585 |
| | Intravascular volume, extracellular fluid volume, and total body water in obese and nonobese hypertensive patients | Q71730055 |
| | Left ventricular filling in young normotensive obese adults | Q72338669 |
| | Hemodynamics and other determinants in development of left ventricular hypertrophy | Q72787710 |
| | Glomerular hemodynamics in severe obesity | Q73782711 |
| | Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects | Q73936894 |
| | Heart failure from the point of view of quantitative anatomy∗ | Q78826681 |
| | Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism | Q24320019 |
| | Association between body mass index and CKD in apparently healthy men | Q28192932 |
| | Global burden of hypertension: analysis of worldwide data | Q28302545 |
| | Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients | Q31140445 |
| | Overweight and hypertension : a 2-way street? | Q33864712 |
| | Link of nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy | Q34313763 |
| | Obesity-associated hypertension: new insights into mechanisms. | Q34374149 |
| | Adipokines: molecular links between obesity and atheroslcerosis | Q34384883 |
| | Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study | Q34539702 |
| | Cardiac remodeling in systemic hypertension | Q35660804 |
| | Recent advances in hypertension, stroke, and cardiorenal disease | Q36163385 |
| | Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Ph | Q36354637 |
| | Obesity, proteinuria and progression of renal failure | Q36568186 |
| | Obesity and renal hemodynamics | Q36575280 |
| | Adipose tissue and atherosclerosis: exploring the connection | Q36736914 |
| | Adipokines in diabetes and cardiovascular diseases | Q36958681 |
| | Endothelial dysfunction in obesity: etiological role in atherosclerosis | Q36973149 |
| | The heart in hypertension: a 1991 overview | Q37111752 |
| | Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss | Q38323163 |
| | Role of circulatory congestion in the cardiorespiratory failure of obesity | Q39585924 |
| | Weight change is associated with change in arterial stiffness among healthy young adults | Q39593602 |
| | Hemodynamic and functional mechanisms in two renal hypertensions: arterial and pyelonephritis | Q39998243 |
| | Renal Parenchymal Hypertension: current concepts of pathogenesis and management | Q40986380 |
| | The problem of obesity and hypertension | Q41587978 |
| | Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies | Q44293250 |
| | The effects of weight loss on renal function in patients with severe obesity | Q44449830 |
| | Weight loss in combination with physical activity improves endothelial dysfunction in human obesity | Q44453182 |
| | Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration. | Q44669038 |
| | Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects | Q44692995 |
| P433 | issue | 2 | |
| P921 | main subject | obesity | Q12174 |
| | arterial hypertension | Q41861 |
| | hemodynamics | Q1642137 |
| P304 | page(s) | 151-155 | |
| P577 | publication date | 2008-04-01 | |
| P1433 | published in | Current Hypertension Reports | Q15746362 |
| P1476 | title | Mechanisms underlying obesity associated with systemic and renal hemodynamics in essential hypertension | |
| P478 | volume | 10 | |